Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Redman

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|December 1, 1989
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinomaP LoRusso, R Pazdur, B G Redman, et al.
CA: a Cancer Journal for Clinicians|May 1, 1993
Immunotherapy of renal cell carcinomaG P Haas, G G Hillman, B G Redman, et al.
American Journal of Clinical Oncology|October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostateK J Pienta, B G Redman, P S Esper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinomaB G Redman, D C Smith, L Flaherty, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinomaB G Redman, Y Abubakr, T Chou, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
The Cancer Journal From Scientific American|February 24, 2000
Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2K Shimizu, R C Fields, B G Redman, et al.
The Western Journal of Medicine|June 1, 1990
Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanomaG R Birchfield, J H Ward, B G Redman, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapyB G Redman, L Flaherty, T H Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinomaB G Redman, G G Hillman, L Flaherty, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|December 1, 1989
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinomaP LoRusso, R Pazdur, B G Redman, et al.
CA: a Cancer Journal for Clinicians|May 1, 1993
Immunotherapy of renal cell carcinomaG P Haas, G G Hillman, B G Redman, et al.
American Journal of Clinical Oncology|October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostateK J Pienta, B G Redman, P S Esper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinomaB G Redman, D C Smith, L Flaherty, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinomaB G Redman, Y Abubakr, T Chou, et al.
Cancer Research|August 1, 1987
Phase I trial of spiromustine (NSC 172112) and evaluation of toxicity and schedule in a murine modelR Pazdur, B G Redman, T Corbett, et al.
The Cancer Journal From Scientific American|February 24, 2000
Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2K Shimizu, R C Fields, B G Redman, et al.
The Western Journal of Medicine|June 1, 1990
Acute pancreatitis associated with high-dose interleukin-2 immunotherapy for malignant melanomaG R Birchfield, J H Ward, B G Redman, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1991
Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapyB G Redman, L Flaherty, T H Chou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinomaB G Redman, G G Hillman, L Flaherty, et al.
Pageof 4